基于人工智能的游离皮瓣术后再手术术前风险模型
该研究基于两个高容量转诊中心649例可分析的游离皮瓣重建成人病例,构建并内部验证了严格术前的多变量模型,用于预测30天内因血管并发症导致的非计划再手术。XGBoost模型区分度最佳(AUC 0.84),但模型尚未达到决策级,需前瞻性外部验证。
要点
- 术前XGBoost模型预测30天再手术AUC为0.84,校准良好。
- 事件率为17.1%,肿瘤病史、手术指征和皮瓣组成是重要预测因素。
- 模型尚不能直接用于临床决策,需前瞻性外部验证。
核心结论
- XGBoost因区分度和校准度综合最优被选为主要模型,随机森林为稳健对照。
- 该模型尚未达到决策级,临床采用前需前瞻性外部验证并重新校准。
研究设计与样本
- 回顾性队列研究,纳入两个高容量转诊中心的650例连续成人病例,其中649例可分析。
- 主要结局为30天内因动脉、静脉、混合血栓形成或临床显著血管痉挛导致的非计划再探查。
- 采用LASSO、随机森林和XGBoost建模,在70%训练集拟合,30%测试集评估。
- 报告遵循TRIPOD,偏倚风险使用PROBAST四域评估。
主要发现
- 事件率为17.1%(111/649)。
- XGBoost区分度最高(AUC 0.84;95%CI 0.74-0.92),校准相对较好(截距0.02,斜率0.87,ICI 0.039,E/O 0.89)。
- 随机森林区分度相当(AUC 0.82;95%CI 0.71-0.90),但校准较差(斜率1.33)。
- LASSO区分度最低(AUC 0.79;95%CI 0.69-0.88)。
- 肿瘤病史、手术指征和皮瓣组成是有影响力的预测因素。
临床怎么用
- 该术前模型可用于术前风险分层,但尚不能直接指导临床决策。
- 临床使用前需进行前瞻性外部验证并重新校准。
局限性
- 模型仅进行内部验证,尚未达到决策级。
- 需要前瞻性外部验证和重新校准后才能临床采用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Flap-related vascular complications requiring surgical reintervention remain a source of morbidity after microsurgical free flap reconstruction and preoperative risk estimation relies on clinical judgement. Therefore, we developed and internally validated a strictly preoperative multivariable model for this outcome. METHODS: A retrospective cohort of 650 consecutive adults at two high-volume referral centres (649 analysable) was analysed. The primary outcome was unplanned re-exploration within 30 days for arterial, venous, mixed thrombosis, or clinically significant vasospasm. Nineteen preoperative predictors were considered; intraoperative and surgeon variables were excluded. Least absolute shrinkage and selection operator (LASSO), random forest, and XGBoost were fitted on a 70% training partition and evaluated on a 30% test set. Performance was assessed using discrimination (AUC), calibration (intercept, slope, ICI, and E/O), and Brier score. Reporting followed TRIPOD; risk of bias used the four-domain PROBAST. RESULTS: Event rate was 17.1% (111/649). XGBoost achieved the highest discrimination (AUC 0.84; 95% CI 0.74-0.92) and relatively better calibration (intercept 0.02, slope 0.87, ICI 0.039, E/O 0.89). Random forest showed comparable discrimination (AUC 0.82; 0.71-0.90) but poorer calibration (slope 1.33). LASSO demonstrated the lowest discrimination (AUC 0.79; 0.69-0.88). Prior oncologic history, surgical indication, and flap composition were influential predictors. A decile table from XGBoost showed a monotonic gradient, with events rising from ≤10% in lower deciles to 80% (95% CI 58-92) in the top decile. CONCLUSIONS: XGBoost is retained as the principal model based on combined superiority in discrimination and calibration, with random forest as a robust comparator. The model is not decision-ready, and prospective external validation with recalibration is required before clinical adoption. LAY SUMMARY: Using 649 analysable free flap reconstructions, we developed preoperative models to predict unplanned surgical reintervention for flap-related vascular complications within 30 days. XGBoost performed the best (AUC 0.84), supporting risk stratification before surgery, but prospective external validation is needed before clinical use.
引用
- Molina Laguna LA, Porras-Ramírez A, Montealegre G, et al. Preoperative artificial intelligence-based risk model for surgical reintervention after microsurgical free flap reconstruction. J Plast Reconstr Aesthet Surg. 2026. PMID: 42546494. doi:10.1016/j.bjps.2026.07.033
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。